Presidio Management Group Viii L L C
10% Owner
Presidio Management Group Viii L L C10% Owner
Presidio Management Group Viii L L C insider trades: OncoMed Pharmaceuticals (OMED) stock buys and sales
10% Owner, OncoMed Pharmaceuticals Last trade Jun 10, 2014 60 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
91
Open-market trades
since 2005
7
Companies
last trade 2014
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Presidio Management Group Viii L L C reports to the SEC
OMEDOncoMed Pharmaceuticals
10% Owner · last filing Aug 12, 2014
-$2.0M
+$5.4M
GWREGuidewire Software
10% Owner · last filing Sep 25, 2012
-$183.7M
ATRCAtriCure
10% Owner · last filing Jun 14, 2012
-$7.2M
MXLMaxlinear
10% Owner · last filing Aug 22, 2012
-$16.4M
IMPVImperva
10% Owner · last filing Nov 15, 2011
+$5.5M
ALTUAltus Pharmaceuticals
10% Owner · last filing Sep 16, 2009
-$195K
and 1 more company
Open-market buys and sales
91 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 10, 2014 | OMED | ↓ Sell | 8,662 | $24.57 | $213K | Directly owned by EP VIII-A | Jun 11, 2014 (1d) |
| Jun 10, 2014 | OMED | ↓ Sell | 4,390 | $24.57 | $108K | Directly owned by EP VIII-B | Jun 11, 2014 (1d) |
| May 15, 2014 | OMED | ↓ Sell | 28,956 | $22.51 | $652K | Directly owned by Federman | May 19, 2014 (4d) |
| May 12, 2014 | OMED | ↓ Sell | 28,956 | $21.99 | $637K | Directly owned by Liddle | May 13, 2014 (1d) |
| May 12, 2014 | OMED | ↓ Sell | 17,371 | $21.98 | $382K | Directly owned by Krausz | May 13, 2014 (1d) |
| Jul 23, 2013 | OMED | ↑ Buy | 155,164 | $17.00 | $2.6M | Directly owned by USVP VIII | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 155,164 | $17.00 | $2.6M | Directly owned by USVP VIII | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 1,498 | $17.00 | $25K | Directly owned by AFF VIII | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 1,498 | $17.00 | $25K | Directly owned by AFF VIII | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 1,434 | $17.00 | $24K | Directly owned by EP VIII-A | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 1,434 | $17.00 | $24K | Directly owned by EP VIII-A | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 727 | $17.00 | $12K | Directly owned by EP VIII-B | Jul 23, 2013 (0d) |
| Jul 23, 2013 | OMED | ↑ Buy | 727 | $17.00 | $12K | Directly owned by EP VIII-B | Jul 23, 2013 (0d) |
| Sep 18, 2012 | GWRE | ↓ Sell | 16,395 | $31.27 | $513K | Directly owned by EP VIII-A | Sep 18, 2012 (0d) |
| Sep 18, 2012 | GWRE | ↓ Sell | 16,395 | $31.27 | $513K | Directly owned by EP VIII-A | Sep 18, 2012 (0d) |
| Sep 18, 2012 | GWRE | ↓ Sell | 8,796 | $31.27 | $275K | Directly owned by EP VIII-B | Sep 18, 2012 (0d) |
| Sep 18, 2012 | GWRE | ↓ Sell | 8,796 | $31.27 | $275K | Directly owned by EP VIII-B | Sep 18, 2012 (0d) |
| Jun 7, 2012 | ATRC | ↓ Sell | 3,279 | $9.44 | $31K | Directly Held by EP VIII-A | Jun 7, 2012 (0d) |
| Jun 7, 2012 | ATRC | ↓ Sell | 3,279 | $9.44 | $31K | Directly Held by EP VIII-A | Jun 7, 2012 (0d) |
| Jun 7, 2012 | ATRC | ↓ Sell | 1,759 | $9.44 | $17K | Directly Held by EP VIII-B | Jun 7, 2012 (0d) |
| Jun 7, 2012 | ATRC | ↓ Sell | 1,759 | $9.44 | $17K | Directly Held by EP VIII-B | Jun 7, 2012 (0d) |
| May 30, 2012 | MXL | ↓ Sell | 3,235 | $4.20 | $14K | Directly owned by EP VIII-A | May 31, 2012 (1d) |
| May 30, 2012 | MXL | ↓ Sell | 3,235 | $4.20 | $14K | Directly owned by EP VIII-A | May 31, 2012 (1d) |
| May 30, 2012 | MXL | ↓ Sell | 1,640 | $4.20 | $7K | Directly owned by EP VIII-B | May 31, 2012 (1d) |
| May 30, 2012 | MXL | ↓ Sell | 1,640 | $4.20 | $7K | Directly owned by EP VIII-B | May 31, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 3,155,311 | $28.25 | $89.1M | Directly owned by USVP VIII | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 3,155,311 | $28.25 | $89.1M | Directly owned by USVP VIII | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 29,561 | $28.25 | $835K | Directly owned by EP VIII-A | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 29,561 | $28.25 | $835K | Directly owned by EP VIII-A | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 23,250 | $28.25 | $657K | Directly owned by AFF VIII | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 23,250 | $28.25 | $657K | Directly owned by AFF VIII | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 15,860 | $28.25 | $448K | Directly owned by EP VIII-B | Apr 25, 2012 (1d) |
| Apr 24, 2012 | GWRE | ↓ Sell | 15,860 | $28.25 | $448K | Directly owned by EP VIII-B | Apr 25, 2012 (1d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 150,823 | $18.00 | $2.7M | Directly owned by USVP VIII | Nov 9, 2011 (0d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 150,823 | $18.00 | $2.7M | Directly owned by USVP VIII | Nov 9, 2011 (0d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 1,392 | $18.00 | $25K | Directly owned by EP VIII-A | Nov 9, 2011 (0d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 1,392 | $18.00 | $25K | Directly owned by EP VIII-A | Nov 9, 2011 (0d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 704 | $18.00 | $13K | Directly owned by EP VIII-B | Nov 9, 2011 (0d) |
| Nov 9, 2011 | IMPV | ↑ Buy | 704 | $18.00 | $13K | Directly owned by EP VIII-B | Nov 9, 2011 (0d) |
| May 27, 2011 | MXL | ↓ Sell | 4,621 | $8.95 | $41K | Directly owned by EP VIII-A | May 31, 2011 (4d) |
| May 27, 2011 | MXL | ↓ Sell | 4,621 | $8.95 | $41K | Directly owned by EP VIII-A | May 31, 2011 (4d) |
| May 27, 2011 | MXL | ↓ Sell | 2,342 | $8.95 | $21K | Directly owned by EP VIII-B | May 31, 2011 (4d) |
| May 27, 2011 | MXL | ↓ Sell | 2,342 | $8.95 | $21K | Directly owned by EP VIII-B | May 31, 2011 (4d) |
| May 26, 2011 | MXL | ↓ Sell | 2,994 | $8.93 | $27K | Directly owned by EP VIII-A | May 26, 2011 (0d) |
| May 26, 2011 | MXL | ↓ Sell | 2,994 | $8.93 | $27K | Directly owned by EP VIII-A | May 26, 2011 (0d) |
| May 26, 2011 | MXL | ↓ Sell | 1,518 | $8.93 | $14K | Directly owned by EP VIII-B | May 26, 2011 (0d) |
| May 26, 2011 | MXL | ↓ Sell | 1,518 | $8.93 | $14K | Directly owned by EP VIII-B | May 26, 2011 (0d) |
| Feb 15, 2011 | MXL | ↓ Sell | 2,552 | $11.54 | $29K | Directly owned by EP VIII-A | Feb 16, 2011 (1d) |
| Feb 15, 2011 | MXL | ↓ Sell | 2,552 | $11.54 | $29K | Directly owned by EP VIII-A | Feb 16, 2011 (1d) |
| Feb 15, 2011 | MXL | ↓ Sell | 1,294 | $11.54 | $15K | Directly owned by EP VIII-B | Feb 16, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Presidio Management Group Viii L L C's insider trades
Presidio Management Group Viii L L C is a 10% owner of OncoMed Pharmaceuticals (OMED). Since Aug 10, 2005, it has reported 14 open-market purchases worth $10.9M and 77 sales worth $209.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (28 filings), conversions (22 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.